Navigation Links
CardioGenics Announces Completion of Cartridge Design for QL Care Analyzer
Date:1/27/2010

MISSISSAUGA, Ontario, Jan. 27 /PRNewswire-FirstCall/ -- CardioGenics Holdings Inc. (OTC Bulletin Board: CGNH), a developer of technology and products targeting the in-vitro diagnostics segment of the Point-Of-Care (POC) diagnostic market, announced today that it has completed the design of the self-metering cartridge for its POC diagnostic device, the QL Care Analyzer. The company has also filed a patent application regarding the self-metering cartridge.

Dr. Yahia Gawad, CEO of CardioGenics, stated, "The completion of the design of the self-metering cartridge is a major milestone in the development of our POC platform. The self-metering cartridge provides our QL Care Analyzer with unprecedented ease of use for a POC diagnostic device, allowing tests to be run on the device by laypersons instead of expensive lab technicians. More importantly, the accuracy of testing will be tremendously improved. This ease of use, combined with the QL Care Analyzer's lab quality sensitivity makes the QL Care Analyzer a unique and much needed offering in the POC diagnostic field."

With the completion of the design of the self-metering cartridge, a limited production run of the self-metering cartridge will now be released, which will enable the company to adapt its first cardiovascular test, Troponin-I, to the self-metering cartridge. Troponin-I is a much-needed test that diagnoses the presence and severity of a heart attack.

CardioGenics anticipates receiving the limited production run of the self-metering cartridges during February 2010. Adaptation of the Troponin-I test to the self-metering cartridge, along with preparations for beta-site testing, will then follow leading up to the anticipated commencement of beta-site testing in mid 2010 at hospitals and laboratories identified by the company. Beta-sit
'/>"/>

SOURCE CardioGenics Holdings Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dr. Yahia Gawad, CEO of CardioGenics Holdings, Inc., Interviewed in MedTech Executive
2. CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads
3. CardioGenics Holdings Inc. Featured in Medical Device Daily
4. CardioGenics Holdings Inc. Announces Letter to Shareholders
5. CardioGenics Holdings Inc. Provides Update on FINRA Submission Regarding Name Change
6. NeuIsys Announces Entrance into the Gastroenterology Market
7. WellWorld Science(R) Announces U.S. Launch of Livea(R),a Safe and Natural Appetite Control Supplement
8. Fuisz Pharma Announces Novel Anti Abuse System for Opiates
9. Perrigo Company Announces Quarterly Dividend
10. ETEX Corporation Announces Distribution Agreement With OrthoPediatrics Corp.
11. Thoratec Announces Acquisition of Innovative Catheter-Based Heart Pump Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... -- Pulse Light Clinic in London,s ... as part of their ongoing research into the condition. They ... their Rosacea. The survey participants were aged between 20 and ... women. The results revealed some rather surprising statistics: ... attempt to visit their GP for Rosacea treatment. ...
(Date:6/30/2015)... 30, 2015 First Choice Wellness Care recently ... Duality and is the only clinic in the greater ... removal treatments. The practice has recently expanded their services ... to showcase their focus in the procedure. They upgraded ... faster ink clearance, and superior service. "We,ve ...
(Date:6/30/2015)... 2015  Avanir Pharmaceuticals, Inc. today announced top-line ... treatment with NUEDEXTA ® was associated with ... affect (PBA) in patients with traumatic brain injury ... characterized by sudden and uncontrollable outbursts of laughing ... brain injury. PRISM II is a phase IV ...
Breaking Medicine Technology:84% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 284% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 3First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 2First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7
... 2011 Fuisz ( www.fuisz.com ) today announced the ... Permitting Stage Door Access to On-Line Vendor Information"). ... "This patent covers a system that allows a customer ... a product supplier database through the on-line vendor,s system ...
... 15, 2011 Cardium Therapeutics (NYSE Amex: ... from the Russian Ministry of Health and Social Development ... Company,s Generx™ (alferminogene tadenovec, Ad5FGF-4) biologic product candidate.  Generx ... for the potential treatment of myocardial ischemia due to ...
Cached Medicine Technology:Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 2Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 3Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 4Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 5Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 6Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 7
(Date:6/30/2015)... ... June 30, 2015 , ... James C. ... & Sarcoma surgery at HackensackUMC and Director of the Skin and Sarcoma division ... distribution of his online Orthopedic Oncology and Pathology Course. The newly installed ...
(Date:6/30/2015)... ... 30, 2015 , ... Tulika Ranjan, MD, a prominent neuro-oncologist ... (AHN) as Director of its Adult Neuro-Oncology program. , Dr. Ranjan’s ... leptomeningeal disease and the neurological complications of cancer. She has special expertise ...
(Date:6/30/2015)... ... 30, 2015 , ... Eldermark Software shakes up the industry ... care sector. As an innovator of senior care software products, Eldermark ... and offer residents better care. , This next-generation interactive system handles all communications ...
(Date:6/30/2015)... ... June 30, 2015 , ... India Network Foundation today announced ... its visitor health insurance plans that provides coverage for visitors to the United States. ... enable visitors to obtain services from most experienced health care professional close to their ...
(Date:6/30/2015)... ... ... to today’s housing market, many people cannot afford to “down size” as they get older. ... to how to carry laundry or groceries from one level of their home to another. ... floor of the home, and the bedrooms are located on another floor. This condition ...
Breaking Medicine News(10 mins):Health News:NJ Top Doc, Dr. James C. Wittig, has Enhanced his Education Portal on TumorSurgery.org 2Health News:NJ Top Doc, Dr. James C. Wittig, has Enhanced his Education Portal on TumorSurgery.org 3Health News:Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program 2Health News:Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program 3Health News:Eldermark Leap-Frogs other Nurse Call and Communication Systems with Notify 2Health News:Eldermark Leap-Frogs other Nurse Call and Communication Systems with Notify 3Health News:India Network Announces Accessibility of First Health PPO Nationwide Network for Visitor Health Insurance Plan Participants Effective July 1, 2015 2Health News:India Network Announces Accessibility of First Health PPO Nationwide Network for Visitor Health Insurance Plan Participants Effective July 1, 2015 3Health News:Butler Mobility Products announce a Solution to Carry Items from One Floor to the Next with a Dumbwaiter 2
... rudeness can have a great impact on relationships far beyond ... in the Journal of Organizational Behavior . Findings suggest ... at the end of the day, it is taken home ... family and partner, who in turn takes the stress to ...
... News) -- ,Scientists who identified significant differences in male ... drug therapies for some diseases. The German researchers ... than 3,000 people and found major gender differences for ... acids. The results prove that "in terms of ...
... Alan Mozes HealthDay Reporter , TUESDAY, Aug. ... with a particularly severe, crippling form of the disease ... recently approved alternative appears to afford relief. A ... no effect on most severe gout patients, but ...
... Cynthia Wu has spent years studying Chang and Eng ... marvels." "The Bunker twins," she says, "have served for ... that while ,individualism, is what makes Americans stand apart ... professor of American studies at the University at Buffalo, ...
... The National Institute of General Medical Sciences of ... Pile, Ph.D., assistant professor of molecular cell biology in ... $1.39 million to research how the alteration of chromatin ... to support the development of cancer treatments currently undergoing ...
... has shown the Flexible-Fiber CO2 laser to safely cut ... the,line of sight problems encountered with conventional CO2 lasers. ... (BMC) and Boston University School of Medicine (BUSM), appear ... This is the first study to report the utility ...
Cached Medicine News:Health News:Baylor University study finds consequences of co-worker rudeness are far-reaching 2Health News:New Drug May Relieve Severe, Tough-to-Treat Gout 2Health News:New Drug May Relieve Severe, Tough-to-Treat Gout 3Health News:New Drug May Relieve Severe, Tough-to-Treat Gout 4Health News:Research on famous Siamese twins demonstrates how the paradox of American identity played out in the bodies of Chang and Eng 2Health News:Research on famous Siamese twins demonstrates how the paradox of American identity played out in the bodies of Chang and Eng 3Health News:NIH awards WSU researcher $1.39M to study chromatin's role in cell division 2Health News:Study finds flexible-fiber CO2 laser safe in endoscopic endonasal transsphenoidal surgery 2
... D-Type can combine a number of ... microplates on a simple to use ... is a multifunctional stand-alone device but ... robotic systems. Custom and standard add-on ...
Grab one and go, One of the smallest handheld oximeters available, Datex-Ohmeda s TuffSat is the ideal spot-check solution for hospital, home care, transport, and EMS. TuffSat comes fully loaded wi...
Smith & Nephew's CDS System is developed exclusively for discography., Developed exclusively for discography, it is the first system designed to measure true disc pressure and record real-time proce...
The Maxi-Therm® lite hyper-hypothermia water blankets from Cincinnati Sub-Zero take conductive warming and cooling therapy to a new, softer level. These blankets are soft, lightweight, and remai...
Medicine Products: